Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Liabilities (2016 - 2025)

Rockwell Medical's Total Liabilities history spans 16 years, with the latest figure at $20.2 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 24.26% year-over-year to $20.2 million; the TTM value through Dec 2025 reached $20.2 million, down 24.26%, while the annual FY2025 figure was $20.2 million, 24.26% down from the prior year.
  • Total Liabilities reached $20.2 million in Q4 2025 per RMTI's latest filing, down from $20.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $47.6 million in Q3 2021 to a low of $20.2 million in Q4 2025.
  • Average Total Liabilities over 5 years is $32.6 million, with a median of $30.5 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: grew 10.3% in 2021, then plummeted 33.88% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $46.0 million in 2021, then fell by 29.34% to $32.5 million in 2022, then fell by 5.06% to $30.9 million in 2023, then fell by 13.79% to $26.6 million in 2024, then dropped by 24.26% to $20.2 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Total Liabilities are $20.2 million (Q4 2025), $20.5 million (Q3 2025), and $22.2 million (Q2 2025).